Hearings to examine advancing national security through export controls, investment security, and the Defense Production Act, including S.3311, to direct the Secretary of Health and Human Services to conduct a demonstration program to test providing preferential treatment under the Medicare, Medicaid, and CHIP programs for certain drugs and biologicals manufactured in the United States.